GRPR and breast carcinoma: A study conducted on human breast cancer patient tissues reported that 51% of them (32/63) showed an overexpression of GRPR together with another receptor called the neuropeptide Y receptor subtype 1 (NPY(Y1)R) (Reubi et al., 2002).